April 28, 2020 / 1:08 PM / a month ago

BRIEF-Philogen says J&J's Janssen unit exercises option on collaboration to identify new molecule-based therapeutics

April 28 (Reuters) -

* PHILOGEN ANNOUNCES OPTION EXERCISE BY JANSSEN

* PHILOGEN: JANSSEN BIOTECH, PART OF JOHNSON & JOHNSON, EXERCISED OPTION THROUGH PARTIES’ DRUG DISCOVERY COLLABORATION TO IDENTIFY NEW SMALL MOLECULE-BASED THERAPEUTICS UTILIZING ITS PHILOCHEM UNIT’S TECHNOLOGIES

* PHILOGEN DOES NOT RELEASE FINANCIAL DETAILS OF AGREEMENT Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below